Literature DB >> 365274

Hodgkin's disease and anergy.

T A Shiftan, J Mendelsohn.   

Abstract

The clinical, pathologic, and immunologic features unique to Hodgkin's disease can be explained by the following hypothesis. A viral transformation of a lymph node cell leads to proliferation of tumor cells and the generation of an immune response consisting of lymphokine production, B cell activation and concomitant suppression of further T cell activation, but ineffective cellular cytotoxicity against the tumor cells. The result of this interaction would be chronic infiltration around the transformed cells, increased immunoglobulin synthesis, and anergy. Failure to destroy the target cells would result in chronicity of these features and progressive disease.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 365274     DOI: 10.1007/bf01082922

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  27 in total

1.  Reversal of cell surface abnormalities of T lymphocytes in hodgkin's disease after in vitro incubation in fetal sera.

Authors:  Z Fuks; S Strober; D P King; H S Kaplan
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

2.  Eosinophil chemotaxis of supernatants from cultured Hodgkin's lymph node cells.

Authors:  A B Kay; J M McVie; A E Stuart; A Krajewski; L W Turnbull
Journal:  J Clin Pathol       Date:  1975-06       Impact factor: 3.411

3.  Lymphocyte reactivity in Hodgkin's disease: a lymphocyte civil war.

Authors:  V T DeVita
Journal:  N Engl J Med       Date:  1973-10-11       Impact factor: 91.245

4.  Lymphocyte activation and destruction in vitro in relation to MLC and HL-A.

Authors:  V P Eijsvoogel; R du Bois; C J Melief; W P Zeylemaker; L Raat-Koning; L de Groot-Kooy
Journal:  Transplant Proc       Date:  1973-09       Impact factor: 1.066

5.  Pathogenesis of Hodgkin's disease.

Authors:  S E Order; S Hellman
Journal:  Lancet       Date:  1972-03-11       Impact factor: 79.321

6.  Prostaglandin-producing suppressor cells in Hodgkin's disease.

Authors:  J S Goodwin; R P Messner; A D Bankhurst; G T Peake; J H Saiki; R C Williams
Journal:  N Engl J Med       Date:  1977-11-03       Impact factor: 91.245

Review 7.  Infection, anergy and cell-mediated immunity.

Authors:  F S Kantor
Journal:  N Engl J Med       Date:  1975-03-20       Impact factor: 91.245

8.  Impaired lymphocyte function in untreated Hodgkin's disease.

Authors:  R Levy; H S Kaplan
Journal:  N Engl J Med       Date:  1974-01-24       Impact factor: 91.245

9.  Cell-mediated immunity to Epstein-Barr-virus-transformed lymphoblastoid cells in acute infectious mononucleosis.

Authors:  I Royston; J L Sullivan; P O Periman; E Perlin
Journal:  N Engl J Med       Date:  1975-12-04       Impact factor: 91.245

10.  "Sternberg-reed" giant cells of Hodgkin's Disease: cultivation in vitro, heterotransplantation, and characterization as neoplastic macrophages.

Authors:  H S Kaplan; S Gartner
Journal:  Int J Cancer       Date:  1977-04-15       Impact factor: 7.396

View more
  1 in total

1.  Pathophysiological aspects of Hodgkin's disease.

Authors:  D Huhn
Journal:  Klin Wochenschr       Date:  1979-05-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.